U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Biologic License Application (BLA): 022175
Company: DIGESTIVE CARE INC

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
PERTZYE PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) 30,250USP UNITS;8,000USP UNITS;28,750USP UNITS CAPSULE, DELAYED RELEASE;ORAL Prescription None No No
PERTZYE PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) 60,500USP UNITS;16,000USP UNITS;57,500USP UNITS CAPSULE, DELAYED RELEASE;ORAL Prescription None No No
PERTZYE PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) 15,125USP UNITS;4,000USP UNITS;14,375USP UNITS CAPSULE, DELAYED RELEASE;ORAL Prescription None No No
PERTZYE PANCRELIPASE (AMYLASE;LIPASE;PROTEASE) 90,750USP UNITS;24,000USP UNITS;86,250USP UNITS CAPSULE, DELAYED RELEASE;ORAL Prescription None No No

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert		 Note Url
02/28/2024 SUPPL-10 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/022175s010lbl.pdf
09/28/2022 SUPPL-8 Labeling-Container/Carton Labels Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf
09/28/2022 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf
09/28/2022 SUPPL-8 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/022175s008lbl.pdf
03/20/2020 SUPPL-6 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022175s006lbl.pdf
03/20/2020 SUPPL-6 Labeling-Medication Guide Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/022175s006lbl.pdf
07/12/2017 SUPPL-4 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022175s004lbl.pdf
05/17/2012 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/022175s000lbl.pdf
Back to Top